Lu Zhao

机构：Fujian Medical University, Chongqing University, HonorHealth, RWTH Aachen University · ORCID：0000-0003-2417-9247

发表论文 28 篇 · 总被引 803 次 · h-index 12

代表论文

• bax , but not bcl-2 , influences the prognosis of human pancreatic cancer (1998 · Gut · 被引 130)
• Moderate Activation of the Apoptosis Inhibitor bcl-xL Worsens the Prognosis in Pancreatic Cancer (1998 · Annals of Surgery · 被引 117)
• MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells (2014 · Oncogene · 被引 106)
• Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer (2015 · Targeted Oncology · 被引 97)
• Expression of the Multidrug-Resistance 1 (MDR1) Gene and Prognosis in Human Pancreatic Cancer (2000 · Pancreas · 被引 52)
• Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT (2018 · Cell Death and Disease · 被引 36)